However, H19 was highly expressed in cancer tissues (p = 0.0036) and showed a significant relationship with RFS (p = 0.0142; Fig. 1E), indicating that HGSC patients with higher H19 expression levels had higher risk of ovarian-cancer recurrence. The gene discussed is H19; the disease is ovarian carcinoma.